Skip to main content

Cibus, Inc.

corporate_fare Company Profile

Cibus, Inc.

CBUS·NASDAQ·Industrial Applications And Services·CIK 0001705843

Cibus is an agricultural biotechnology company that develops specific genetic characteristics, called plant traits, in the DNA of plant seeds using proprietary gene editing technologies. These traits influence how a plant functions or interacts with its environment. Cibus aims to change the scale and speed of plant breeding for major agricultural crops through its unique process. The company has developed a proprietary gene editing platform called the Rapid Trait Development System™ (RTDS®). This system allows Cibus to edit gene targets for novel traits, which can be integrated into customers' elite seed genetics in as little as one year. Cibus operates within the global seed market, where management estimates the aggregate trait value across both genetically modified organism (GMO) and non-GMO seeds globally is approximately $12.0 billion. Cibus' primary business focuses on developing plant traits for major agricultural crops to address productivity, profitability, sustainability, or yield challenges in farming. These plant traits can be licensed to seed companies for inclusion in their seed products, generating royalties for Cibus.

Cibus, Inc. (NASDAQ:CBUS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 22 items for CBUS at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Cibus Details Strategic Focus and Cost Reductions Amidst Equity Offering
  • Cibus, Inc. Announces Preliminary Equity Offering Amidst Going Concern Warning; Directors Indicate $1.5M Purchase

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$3.64M
Net Income
-$127.08M
Diluted EPS
-$2.78
Op. Cash Flow
-$50.59M
Free Cash Flow
-$51.17M
Operating Income
-$97.53M
Cash & Equivalents
$9.92M
Total Debt
$528K
Debt / Equity
0.02×
Net Margin
-34.92×
Shares Outstanding
45.76M sh
Source: 10-K · filed 2026-03-17 · accession 0001628280-26-018815
$1.61
52-week range · as of 2026-08-13 $1.09 – $4.19
Market cap
$123.05M
Volume
139.1K (1.1× avg)
3-mo avg 128.5K
Live data · 2026-09-20 11:13 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CBUS - Filings & News (Page 2)

CBUS
Jan 28, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.53
Real-time Price: $1.61 info
Change: +$0.080 (+5%) info
Market Cap: $123.051M info
CBUS
Jan 28, 2026, 4:08 PM EST
Filing Type: 424B5
Importance Score:
8
Price at Filing: $1.56
Real-time Price: $1.61 info
Change: +$0.050 (+3%) info
Market Cap: $123.051M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets